Juan Brignardello Vela
Juan Brignardello Vela, asesor de seguros, se especializa en brindar asesoramiento y gestión comercial en el ámbito de seguros y reclamaciones por siniestros para destacadas empresas en el mercado peruano e internacional.
In a recent development that promises to enhance the landscape of biomedical research, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center has appointed Dr. Joe W. Ramos as its new President and Chief Executive Officer, effective January 21, 2025. This strategic leadership change comes at a pivotal time as the institute seeks to amplify its mission of advancing scientific discovery and improving health outcomes on both a local and global scale. Dr. Ramos transitions from the Louisiana Cancer Research Center, where he served with distinction as Director and CEO. His impressive background in cancer research and his extensive experience in promoting collaborative scientific initiatives have positioned him as a formidable leader in the field. With a career that has been marked by groundbreaking research and innovation, Dr. Ramos has dedicated himself to understanding the complexities of cancer signaling and metastasis, particularly in brain, kidney, and skin cancers. His contributions have not only advanced the scientific community's understanding of cancer but have also led to the development of potential therapies aimed at inhibiting tumor growth and invasion. As he takes the helm at The Lundquist Institute, Dr. Ramos will oversee an expansive research portfolio that encompasses over 600 active studies conducted by 100 principal investigators. This multidisciplinary approach spans various domains, including genetics, infectious diseases, cardiology, cancer, regenerative medicine, and public health. His appointment signals a commitment to fostering an environment where innovation thrives and where collaborative research can lead to breakthroughs that save lives. In welcoming Dr. Ramos, Mitchel Sayare, Chair of The Lundquist Institute's Board of Directors, expressed enthusiasm about his leadership abilities, stating, “His exceptional leadership and vision will be pivotal as we advance biomedical research and develop innovative solutions to improve global health.” This sentiment underscores the high expectations placed on Dr. Ramos as he steps into a role crucial for the future of biomedical research. Dr. Ramos expressed his commitment to the institute’s mission, emphasizing his eagerness to work alongside the talented team at The Lundquist Institute. “I am honored to join The Lundquist Institute, an organization with a distinguished legacy of biomedical innovation and a steadfast commitment to improving community and global health,” he remarked. His vision aligns with the institute’s ongoing goal to engage with communities and stakeholders while promoting education and research that can lead to significant advancements in healthcare. Dr. Ramos succeeds Dr. Marianne Gausche-Hill, who served as Interim President and CEO since December 2023. The Board has recognized her contributions during this transitional period, highlighting the importance of stable leadership in guiding the institute during times of change. The Lundquist Institute has been a pivotal player in the biomedical field since its establishment in 1952, continuously driving advancements in medical research and patient care. With Dr. Ramos at the helm, The Lundquist Institute is poised to further its impact within Los Angeles County and beyond, reinforcing its status as a leading nonprofit research organization dedicated to saving lives through innovation.